Germany
Japan
United Kingdom
China
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
Antibodies
View as table Download
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against PROX1 (Center)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PROX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 185-214 amino acids from the Central region of human PROX1. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
Rabbit polyclonal RUNX1 Antibody (S276)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This RUNX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 227-255 amino acids from human RUNX1. |
Rabbit polyclonal KLF5 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-370 amino acids from the C-terminal region of human KLF5. |
PIM1 Antibody (C-term ) Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PIM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 374-404 amino acids from the C-terminal region of human PIM1. |
Rabbit Polyclonal CCR5 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | CCR5 antibody was raised against a 15 amino acid peptide near the amino terminus of human CCR5. The immunogen is located within the first 50 amino acids of CCR5. |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
WISP2 Rabbit Polyclonal (aa102-117) Antibody
| Applications | IHC |
| Reactivities | Human |
| Immunogen | WISP2 antibody was raised against synthetic peptide from human WISP2. |
Rabbit Polyclonal Antibody against SOX2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SOX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 89-119 amino acids from the N-terminal region of human SOX2. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
Thy-1 / CD90 Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human, Monkey, Orang-Utan |
| Conjugation | Unconjugated |
| Immunogen | THY1 / CD90 antibody was raised against synthetic peptide C-PEHTYRSRTNFTSKY from an internal region of human THY1 (NP_006279.2). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset (100%); Panda, Dog, Horse (93%); Pig (87%); Elephant, Rabbit, Guinea pig (80%). |
Anti-Human IGF-I Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human IGF-I |
Rabbit polyclonal SOX-9 (Ser181) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human SOX-9 around the phosphorylation site of serine 181 (R-K-SP-V-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal PDGFR beta (Ab-1021) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PDGFR β around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I). |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Active filters
Applications
- IHC
Clonalities
- Polyclonal
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Category
Target Symbol
- AKT1 (8)
- GCG (6)
- JUN (5)
- SRC (4)
- STAT5B (4)
- AKT2 (3)
- BSG (3)
- CSNK1A1 (3)
- CXCR4 (3)
- HNF1B (3)
- PIK3CG (3)
- PRKCA (3)
- SMAD1 (3)
- SOX2 (3)
- ACTB (2)
- AKT3 (2)
- ALDH1A1 (2)
- ANGPT1 (2)
- BDNF (2)
- BGLAP (2)
- CASP3 (2)
- CCR5 (2)
- CD44 (2)
- CD93 (2)
- CDCA4 (2)
- CDH1 (2)
- CEBPA (2)
- CSNK2A1 (2)
- CTNNB1 (2)
- CYP3A4 (2)
- EGF (2)
- ENPEP (2)
- FGF18 (2)
- FGF7 (2)
- FN1 (2)
- GATA3 (2)
- GATA6 (2)
- HCRTR1 (2)
- ICAM1 (2)
- ID2 (2)
- ID4 (2)
- IGF1 (2)
- MAP2 (2)
- MAPK8 (2)
- MYB (2)
- NES (2)
- NOTCH1 (2)
- PDX1 (2)
- PIM1 (2)
- PLAU (2)
- PROX1 (2)
- SERPINA1 (2)
- SFRP1 (2)
- SHH (2)
- SIGLEC7 (2)
- SIPA1 (2)
- SMAD5 (2)
- SOX11 (2)
- SP1 (2)
- TCF3 (2)
- TEK (2)
- TNFRSF8 (2)
- TUBB3 (2)
- YBX1 (2)
- A1BG (1)
- ABCB1 (1)
- ACE (1)
- ACTN1 (1)
- ACVR1 (1)
- ADGRE5 (1)
- ALCAM (1)
- ANGPTL2 (1)
- ANGPTL5 (1)
- ANPEP (1)
- APH1A (1)
- AXIN1 (1)
- BMP15 (1)
- CCN1 (1)
- CCN3 (1)
- CCN5 (1)
- CD244 (1)
- CD69 (1)
- CDCP1 (1)
- CDH5 (1)
- CDX2 (1)
- CEBPB (1)
- CGA (1)
- CHRDL1 (1)
- CSF1 (1)
- CSF3R (1)
- CST3 (1)
- DHH (1)
- DKK2 (1)
- DKK4 (1)
- DLL4 (1)
- DLX5 (1)
- DVL2 (1)
- FAS (1)
- FCGR2B (1)
- FCGR3A (1)
Reactivities
Antibody Hosts
Conjugates
Modifications
Pathways
- Pathways in cancer (76)
- Focal adhesion (52)
- ErbB signaling pathway (39)
- MAPK signaling pathway (39)
- Colorectal cancer (33)
- Wnt signaling pathway (33)
- Melanoma (32)
- Acute myeloid leukemia (30)
- Jak-STAT signaling pathway (28)
- Neurotrophin signaling pathway (27)
- Prostate cancer (27)
- Tight junction (27)
- Chemokine signaling pathway (26)
- Regulation of actin cytoskeleton (26)
- Endometrial cancer (25)
- Glioma (25)
- Toll-like receptor signaling pathway (25)
- VEGF signaling pathway (25)
- Leukocyte transendothelial migration (24)
- Renal cell carcinoma (24)
- T cell receptor signaling pathway (24)
- B cell receptor signaling pathway (23)
- Chronic myeloid leukemia (23)
- Fc epsilon RI signaling pathway (23)
- Fc gamma R-mediated phagocytosis (23)
- Progesterone-mediated oocyte maturation (23)
- Cytokine-cytokine receptor interaction (22)
- Insulin signaling pathway (22)
- Non-small cell lung cancer (22)
- Pancreatic cancer (22)
- Small cell lung cancer (21)
- mTOR signaling pathway (20)
- Apoptosis (19)
- Adipocytokine signaling pathway (18)
- Cell adhesion molecules (CAMs) (18)
- Endocytosis (17)
- GnRH signaling pathway (17)
- Natural killer cell mediated cytotoxicity (17)
- Adherens junction (15)
- TGF-beta signaling pathway (15)
- Basal cell carcinoma (14)
- Epithelial cell signaling in Helicobacter pylori infection (14)
- Gap junction (14)
- Hedgehog signaling pathway (14)
- Hematopoietic cell lineage (14)
- Melanogenesis (14)
- Pathogenic Escherichia coli infection (12)
- Type II diabetes mellitus (11)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (10)
- Hypertrophic cardiomyopathy (HCM) (10)
- Dilated cardiomyopathy (9)
- ECM-receptor interaction (9)
- Metabolic pathways (9)
- Maturity onset diabetes of the young (8)
- Viral myocarditis (8)
- Alzheimer's disease (6)
- Axon guidance (6)
- Huntington's disease (6)
- Long-term depression (6)
- Notch signaling pathway (6)
- Phosphatidylinositol signaling system (6)
- Thyroid cancer (6)
- Bladder cancer (5)
- Vibrio cholerae infection (5)
- p53 signaling pathway (5)
- Autoimmune thyroid disease (4)
- Calcium signaling pathway (4)
- Complement and coagulation cascades (4)
- Long-term potentiation (4)
- NOD-like receptor signaling pathway (4)
- Neuroactive ligand-receptor interaction (4)
- Oocyte meiosis (4)
- Prion diseases (4)
- Renin-angiotensin system (4)
- Retinol metabolism (4)
- Vascular smooth muscle contraction (4)
- Amyotrophic lateral sclerosis (ALS) (3)
- Dorso-ventral axis formation (3)
- Inositol phosphate metabolism (3)
- RIG-I-like receptor signaling pathway (3)
- Systemic lupus erythematosus (3)
- Type I diabetes mellitus (3)
- Allograft rejection (2)
- Antigen processing and presentation (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Glycolysis / Gluconeogenesis (2)
- Graft-versus-host disease (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Parkinson's disease (2)
- Tyrosine metabolism (2)
- ABC transporters (1)
- Cardiac muscle contraction (1)
- Citrate cycle (TCA cycle) (1)
- Cysteine and methionine metabolism (1)
- Glutathione metabolism (1)
- Lysosome (1)
- PPAR signaling pathway (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Primary immunodeficiency (1)
- Pyruvate metabolism (1)
- Regulation of autophagy (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- Ubiquitin mediated proteolysis (1)
- tyrosine and tryptophan biosynthesis (1)